Literature DB >> 32505907

Surgical management of middle cranial fossa bone defects: meningoencephalic herniation and cerebrospinal fluid leaks.

Elena Hernandez-Montero1, Erika Caballero2, Luis García-Ibanez2.   

Abstract

Along the medical practice of an Otologist he/she will face middle cranial fossa (MCF) bone defects. The purpose of this study is to contribute to the understanding of this possible life threatening condition, and to share and discuss our management approach. A literature review is also presented. STUDY
DESIGN: Retrospective case series at García-Ibáñez Otology and Skull base private center referral.
METHODS: This study is based on the analysis of data collected from 19 cases of temporal bone meningoencephalic herniations surgically treated from 2006 to 2018. The follow-up ranged from 18 to 162 months with a mean average of 44.5 months. MAIN
FINDINGS: Meningoencephalic herniations were divided into four etiologic groups: spontaneous (24.8%), secondary to chronic otitis media (21.8%), iatrogenic (45.9%), and posttraumatic (7.5%). Different surgical techniques were used as treatment: transmastoid (TM) approach (27.8%), MCF approach (27.8%), combined technique (transmastoid plus minicraniotomy, 3%), and middle ear obliteration with blind sac closure of the external auditory canal (41.4%).
CONCLUSIONS: Variables like bilateral hearing level, size and location of the bone defect and existence of CSF leak should be analyzed to select the safest and most effective closing surgical approach.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebrospinal fluid (CSF) leak; Meningoencephalic herniation; Middle cranial Fossa; Temporal bone defect

Year:  2020        PMID: 32505907     DOI: 10.1016/j.amjoto.2020.102560

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  1 in total

1.  Outcomes after mini-craniotomy middle fossa approach combined with mastoidectomy for lateral skull base defects.

Authors:  Amit Walia; Daniel Lander; Nedim Durakovic; Matthew Shew; Cameron C Wick; Jacques Herzog
Journal:  Am J Otolaryngol       Date:  2020-10-24       Impact factor: 1.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.